Search Results 1891-1900 of 16562 for Epilepsy (Partial Onset)

  1. A Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial

    Note: WOCBP must agree to follow instructions for method(s) of contraception for the duration of the study, for 2 years following implantation of the device.

  2. Publications - Prashant Kapoor, M.D. - Mayo Clinic

    ... onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma. Blood Cancer J. 2025 Dec 31; 16 (1):18. View PubMed; Hellou T, Kumar SK ...

  3. Neurology - Doctors - Mayo Clinic

    D. Neurologist. Rochester, MN. Areas of focus: EEG, Epilepsy. Chris J. Lamb, M.D.. Neurologist. Jacksonville, FL. Areas of focus ...

  4. Pediatric Brain Tumors Clinical Trials - Mayo Clinic Research

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  5. Diseases and Conditions - Clinical Trials - Mayo Clinic Research

    Young-onset colon cancer · Young-onset rectal cancer . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees · Site ...

  6. Headache: First aid - Mayo Clinic

    Causes mental confusion or loss of consciousness. Happens with seizures. Immediate medical attention also is needed if your headache occurs with new: Dizziness ...

  7. Articaine and epinephrine (injection route) - Side effects & uses - Mayo Clinic

    Articaine and epinephrine combination injection is used to numb the mouth before a dental procedure. This medicine is to be given by or under the direct ...

  8. Study Finds Trigger of Paralysis Complication in Neuromyelitis Optica - Mayo Clinic News Network

    ... epilepsy, stroke, and autoimmune neurology. In addition to Drs. Wu and Lennon, other Mayo authors are Tingjun Chen, M.D., Ph.D., Yong Liu, Ph.D., Dale Bosco ...

  9. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with ...

  10. Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy - Mayo Clinic

    About this study. This study is an observational study to determine predictors of sudden cardiac death or appropriate ICD therapy in patients with ...